Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor Activation
- PMID: 31100979
- PMCID: PMC6572030
- DOI: 10.3390/molecules24101892
Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor Activation
Abstract
In this work we summarize our understanding of melanocortin 4 receptor (MC4R) pathway activation, aiming to define a safe and effective therapeutic targeting strategy for the MC4R. Delineation of cellular MC4R pathways has provided evidence for distinct MC4R signaling events characterized by unique receptor activation kinetics. While these studies remain narrow in scope, and have largely been explored with peptidic agonists, the results provide a possible correlation between distinct ligand groups and differential MC4R activation kinetics. In addition, when a set of small-molecule and peptide MC4R agonists are compared, evidence of biased signaling has been reported. The results of such mechanistic studies are discussed.
Keywords: GαS signaling; cardiovascular profile; melanocortin-4 receptor; obesity; peptide agonist; receptor desensitization; receptor internalization.
Conflict of interest statement
All authors are employees of Rhythm Pharmaceuticals.
Similar articles
-
Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.Int J Mol Sci. 2020 Aug 10;21(16):5728. doi: 10.3390/ijms21165728. Int J Mol Sci. 2020. PMID: 32785054 Free PMC article. Review.
-
Temporal cAMP Signaling Selectivity by Natural and Synthetic MC4R Agonists.Mol Endocrinol. 2015 Nov;29(11):1619-33. doi: 10.1210/me.2015-1071. Epub 2015 Sep 29. Mol Endocrinol. 2015. PMID: 26418335 Free PMC article.
-
SHU9119 and MBP10 are biased ligands at the human melanocortin-4 receptor.Biochem Pharmacol. 2024 Oct;228:116325. doi: 10.1016/j.bcp.2024.116325. Epub 2024 May 28. Biochem Pharmacol. 2024. PMID: 38815629
-
Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway.Mol Cell Endocrinol. 2012 Jan 2;348(1):47-54. doi: 10.1016/j.mce.2011.07.036. Epub 2011 Jul 22. Mol Cell Endocrinol. 2012. PMID: 21803120
-
Melanocortin-4 receptor agonists for the treatment of obesity.Curr Top Med Chem. 2007;7(11):1121-30. doi: 10.2174/156802607780906636. Curr Top Med Chem. 2007. PMID: 17584132 Review.
Cited by
-
Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R).Physiol Res. 2020 Sep 30;69(Suppl 2):S245-S254. doi: 10.33549/physiolres.934512. Physiol Res. 2020. PMID: 33094623 Free PMC article. Review.
-
Signal Transduction and Pathogenic Modifications at the Melanocortin-4 Receptor: A Structural Perspective.Front Endocrinol (Lausanne). 2019 Jul 31;10:515. doi: 10.3389/fendo.2019.00515. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31417496 Free PMC article.
-
Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In Vivo.J Clin Med. 2025 Feb 11;14(4):1165. doi: 10.3390/jcm14041165. J Clin Med. 2025. PMID: 40004697 Free PMC article.
-
Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.Int J Mol Sci. 2020 Aug 10;21(16):5728. doi: 10.3390/ijms21165728. Int J Mol Sci. 2020. PMID: 32785054 Free PMC article. Review.
-
Next Generation Antiobesity Medications: Setmelanotide, Semaglutide, Tirzepatide and Bimagrumab: What do They Mean for Clinical Practice?J Obes Metab Syndr. 2021 Sep 30;30(3):196-208. doi: 10.7570/jomes21033. J Obes Metab Syndr. 2021. PMID: 34518444 Free PMC article. Review.
References
-
- Cone R.D. The central melanocortin system and its role in energy homeostasis. Ann. Endocrinol. 1999;60:3–9. - PubMed
-
- Collet T.H., Dubern B., Mokrosinski J., Connors H., Keogh J.M., Mendes de Oliveira E., Henning E., Poitou-Bernert C., Oppert J.M., Tounian P., et al. Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency. Mol. Metab. 2017;6:1321–1329. doi: 10.1016/j.molmet.2017.06.015. - DOI - PMC - PubMed
-
- Clément K., Biebermann H., Farooqi I.S., Van der Ploeg L., Wolters B., Poitou C., Puder L., Fiedorek F., Gottesdiener K., Kleinau G., et al. MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency. Nat. Med. 2018;24:551–555. doi: 10.1038/s41591-018-0015-9. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources